Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$1.32B |
| 2 |
Visa
V
|
+$1.31B |
| 3 |
Philip Morris
PM
|
+$1.14B |
| 4 |
Netflix
NFLX
|
+$1.05B |
| 5 |
Apple
AAPL
|
+$844M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.54B |
| 2 |
Wells Fargo
WFC
|
+$1.16B |
| 3 |
Oracle
ORCL
|
+$801M |
| 4 |
CVS Health
CVS
|
+$576M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$525M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.3% |
| 2 | Financials | 15.43% |
| 3 | Technology | 12.33% |
| 4 | Industrials | 10.98% |
| 5 | Energy | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Merck
MRK
$359B
| $9.41B | 2.36% |
158,059,551
-26,332,277
| -14% | -$1.54B |
2013 Q2
13 quarters
|
|
2
Microsoft
MSFT
$3.97T
| $7.91B | 1.98% |
137,281,143
-5,676,951
| -4% | -$320M |
2013 Q2
13 quarters
|
|
3
Bristol-Myers Squibb
BMY
$121B
| $7.36B | 1.84% |
136,423,757
+6,808,847
| +5% | +$437M |
2013 Q2
13 quarters
|
|
4
UnitedHealth
UNH
$340B
| $7.12B | 1.78% |
50,864,602
-1,784,256
| -3% | -$250M |
2013 Q2
13 quarters
|
|
5
Medtronic
MDT
$113B
| $6.36B | 1.59% |
73,668,189
-2,298,873
| -3% | -$200M |
2013 Q2
13 quarters
|
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $5.56B | 1.39% |
24,155,925
+273,953
| +1% | +$66.9M |
2013 Q2
13 quarters
|
|
|
7
Wells Fargo
WFC
$253B
| $4.66B | 1.17% |
105,287,458
-24,175,313
| -19% | -$1.16B |
2013 Q2
13 quarters
|
|
8
Intel
INTC
$553B
| $4.59B | 1.15% |
121,661,970
+21,796,695
| +22% | +$772M |
2013 Q2
13 quarters
|
|
9
Johnson & Johnson
JNJ
$630B
| $4.52B | 1.13% |
38,304,770
-799,832
| -2% | -$97M |
2013 Q2
13 quarters
|
|
10
JPMorgan Chase
JPM
$885B
| $4.52B | 1.13% |
67,947,925
-574,284
| -0.8% | -$37.4M |
2013 Q2
13 quarters
|
|
11
ExxonMobil
XOM
$695B
| $4.46B | 1.12% |
51,104,897
+2,976,158
| +6% | +$264M |
2013 Q2
13 quarters
|
|
12
Chubb
CB
$132B
| $4.28B | 1.07% |
34,089,833
+228,757
| +0.7% | +$29M |
2013 Q2
13 quarters
|
|
13
Chevron
CVX
$416B
| $4.18B | 1.05% |
40,604,933
+1,014,707
| +3% | +$104M |
2013 Q2
13 quarters
|
|
|
14
Apple
AAPL
$4.91T
| $3.8B | 0.95% |
134,583,900
+31,884,464
| +31% | +$844M |
2013 Q2
13 quarters
|
|
15
PNC Financial Services
PNC
$87.5B
| $3.78B | 0.95% |
41,935,947
+273,365
| +0.7% | +$23.5M |
2013 Q2
13 quarters
|
|
|
16
McKesson
MCK
$109B
| $3.71B | 0.93% |
22,247,215
+7,067,950
| +47% | +$1.32B |
2013 Q2
13 quarters
|
|
17
Alphabet (Google) Class A
GOOGL
$4.3T
| $3.65B | 0.91% |
90,743,380
-702,560
| -0.8% | -$27.5M |
2015 Q4
3 quarters
|
|
18
Eli Lilly
LLY
$1.05T
| $3.62B | 0.91% |
45,145,736
+1,815,234
| +4% | +$145M |
2013 Q2
13 quarters
|
|
19
Cisco
CSCO
$467B
| $3.6B | 0.9% |
113,533,153
-1,195,019
| -1% | -$36.8M |
2013 Q2
13 quarters
|
|
20
Honeywell
HON
$65.8B
| $3.54B | 0.89% |
33,797,970
-1,851,045
| -5% | -$193M |
2013 Q2
13 quarters
|
|
21
Comcast
CMCSA
$73.3B
| $3.39B | 0.85% |
102,162,096
-4,500,002
| -4% | -$150M |
2013 Q2
13 quarters
|
|
|
MRSH
22
Marsh
MRSH
$83.9B
| $3.31B | 0.83% |
49,262,033
-2,228,212
| -4% | -$149M |
2013 Q2
13 quarters
|
|
23
Blackrock
BLK
$168B
| $3.27B | 0.82% |
9,032,269
+100,756
| +1% | +$36.7M |
2013 Q2
13 quarters
|
|
24
Verizon
VZ
$173B
| $3.24B | 0.81% |
62,415,646
-6,434,558
| -9% | -$345M |
2013 Q2
13 quarters
|
|
25
United Parcel Service
UPS
$80.5B
| $3.23B | 0.81% |
29,532,690
+7,798
| +0% | +$852K |
2013 Q2
13 quarters
|
|
Similar funds
Wellington Management Group's Q3 2016 Portfolio in Review
As of Q3 2016, Wellington Management Group held 2,342 positions worth $399B, up 3.2% from $387B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wellington Management Group's Q3 2016 filing shows 267 new, 876 increased, 813 reduced and 168 closed positions. Its largest new stake was Fortive: 8,256,653 shares worth $265M. The largest sale was Merck, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q3 2016 buy was Fortive: 8,256,653 shares worth $265M.
- Wellington Management Group added most to McKesson in Q3 2016, an estimated $1.32B increase.
- Wellington Management Group's biggest Q3 2016 reduction was Merck, cutting an estimated $1.54B.
- Wellington Management Group fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $327M.
- Wellington Management Group's ten largest holdings make up 16% of its $399B portfolio in Q3 2016.
- Wellington Management Group opened 267 new positions and closed 168 in Q3 2016.
- Wellington Management Group's portfolio value rose 3.2% quarter-over-quarter to $399B.
Based on Wellington Management Group's 13F filing for Q3 2016, filed 14 Nov 2016.